SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-294020
Filing Date
2019-11-18
Accepted
2019-11-18 12:41:13
Documents
3
Group Members
PABLO G. LEGORRETARP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d832942dsc13d.htm SC 13D 70421
2 EX-99.A d832942dex99a.htm EX-99.A 5446
3 EX-99.B d832942dex99b.htm EX-99.B 63162
  Complete submission text file 0001193125-19-294020.txt   140606
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87481 | Film No.: 191226709
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RPI Finance Trust (Filed by) CIK: 0001793690 (see all company filings)

IRS No.: 456358481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D